Search Results - Shah, Humra

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671

    A Phase II Clinical Trial of Fludarabine and Cyclophosphamide Followed by Thalidomide for Angioimmunoblastic Lymphoma (AITL), an NCRI Clinical Trial. CRUK C17050/A5671 by Townsend, William M, Johnson, Roderick J., Counsell, Nicholas, Shah, Humra, Pottinger, Bryson, Evans, Katy, Wickham, Caroline, Smith, Paul, Claudius, Rudin

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Rituximab and CODOX-M / IVAC Without Stem Cell Transplantation For Poor Risk Diffuse Large B Cell Lymphoma (IPI3-5) and Burkitts Lymphoma Is Feasible and Gives a High Response Rate: Preliminary Results Of a Phase 2 UK National Cancer Research Institute Trial

    Rituximab and CODOX-M / IVAC Without Stem Cell Transplantation For Poor Risk Diffuse Large B Cell Lymphoma (IPI3-5) and Burkitts Lymphoma Is Feasible and Gives a High Response Rate... by McMillan, Andrew, Ardeshna, Kirit M, Gambell, Jo, Jack, Andrew, Kirkwood, Amy, Laurie, Anthony, Montoto, Silvia, Paneesha, Shankaranarayana, Rule, Simon, Patmore, Russell, Pettengell, Ruth, Shah, Humra, Smith, Paul, Linch, David

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Mutual Fund Industry and its Prospects in Indian Scenario

    Mutual Fund Industry and its Prospects in Indian Scenario by Shah, Ragini, Humra, Yashba

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: